Lauri Tuure
Tampere, 33014, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Dexamethasone Attenuates the Expression of MMP-13 in Chondrocytes through MKP-1.
Journal: International journal of molecular sciences
Published: February 10, 2022
Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
Journal: Scandinavian journal of rheumatology
Published: July 15, 2021
Transient Receptor Potential Ankyrin 1 (TRPA1) Is Involved in Upregulating Interleukin-6 Expression in Osteoarthritic Chondrocyte Models.
Journal: International journal of molecular sciences
Published: September 30, 2020
Regulation of gene expression by MF63, a selective inhibitor of microsomal PGE synthase 1 (mPGES1) in human osteoarthritic chondrocytes.
Journal: British journal of pharmacology
Published: June 10, 2019
Downregulation of microsomal prostaglandin E synthase-1 (mPGES-1) expression in chondrocytes is regulated by MAP kinase phosphatase-1 (MKP-1).
Journal: International immunopharmacology
Published: January 16, 2019
Microsomal Prostaglandin E Synthase-1 Expression in Inflammatory Conditions Is Downregulated by Dexamethasone: Seminal Role of the Regulatory Phosphatase MKP-1.
Journal: Frontiers in pharmacology
Published: June 22, 2017
PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1.
Journal: Pharmacology research & perspectives
Published: May 24, 2017
Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes.
Journal: Scandinavian journal of rheumatology
Published: October 15, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026